AGIOS PHARMACEUTICALS, INC.
Total Trades
140
Buys
0
Sells
76
Largest Trade
N/A
Insiders
11
Institutional Funds
178
Inst. Value
$1M+
Activist Filings
34
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Washburn Theodore James Jr. | Principal Accounti… | SELL | $100K–$500K | 5K | $28.88 | Mar 5, 2026 |
| Goff Brian | CEO | SELL | $500K+ | 18K | $28.96 | Mar 3, 2026 |
| Goff Brian | CEO | EXERCISE | N/A | 40K | — | Mar 3, 2026 |
| Burns James William | Chief Legal Officer | SELL | $100K–$500K | 5K | $28.96 | Mar 3, 2026 |
| Burns James William | Chief Legal Officer | EXERCISE | N/A | 18K | — | Mar 3, 2026 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $100K–$500K | 4K | $28.96 | Mar 3, 2026 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | N/A | 14K | — | Mar 3, 2026 |
| Jones Cecilia | CFO | EXERCISE | N/A | 17K | — | Mar 3, 2026 |
| Jones Cecilia | CFO | SELL | $100K–$500K | 5K | $28.96 | Mar 3, 2026 |
| Milanova Tsveta | Chief Commercial O… | EXERCISE | N/A | 10K | — | Mar 3, 2026 |
| Milanova Tsveta | Chief Commercial O… | SELL | $50K–$100K | 3K | $28.96 | Mar 3, 2026 |
| Washburn Theodore James Jr. | Principal Accounti… | SELL | $50K–$100K | 2K | $28.96 | Mar 3, 2026 |
| Washburn Theodore James Jr. | Principal Accounti… | EXERCISE | N/A | 7K | — | Mar 3, 2026 |
| Milanova Tsveta | Chief Commercial O… | SELL | $50K–$100K | 3K | $27.02 | Jan 7, 2026 |
| Milanova Tsveta | Chief Commercial O… | EXERCISE | N/A | 8K | — | Jan 7, 2026 |
| Burns James William | Chief Legal Officer | EXERCISE | N/A | 6K | — | Jan 3, 2026 |
| Burns James William | Chief Legal Officer | SELL | $50K–$100K | 3K | $27.09 | Jan 3, 2026 |
| Goff Brian | CEO | EXERCISE | N/A | 38K | — | Jan 3, 2026 |
| Goff Brian | CEO | SELL | $500K+ | 19K | $27.09 | Jan 3, 2026 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $50K–$100K | 3K | $27.09 | Jan 3, 2026 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | N/A | 6K | — | Jan 3, 2026 |
| Milanova Tsveta | Chief Commercial O… | EXERCISE | N/A | 6K | — | Jan 3, 2026 |
| Milanova Tsveta | Chief Commercial O… | SELL | $50K–$100K | 3K | $27.09 | Jan 3, 2026 |
| Jones Cecilia | CFO | EXERCISE | N/A | 6K | — | Jan 3, 2026 |
| Jones Cecilia | CFO | SELL | $50K–$100K | 3K | $27.09 | Jan 3, 2026 |
| Scadden David | Director | EXERCISE | $1K–$15K | 200 | $18.09 | Nov 14, 2025 |
| Scadden David | Director | SELL | $1K–$15K | 200 | $43.84 | Nov 14, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | $50K–$100K | 2K | $25.01 | Nov 13, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $100K–$500K | 2K | $43.78 | Nov 13, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | $1K–$15K | 200 | $25.01 | Nov 3, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $1K–$15K | 200 | $43.81 | Nov 3, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | $50K–$100K | 3K | $25.01 | Oct 29, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $100K–$500K | 3K | $43.92 | Oct 29, 2025 |
| Scadden David | Director | EXERCISE | $1K–$15K | 200 | $18.09 | Oct 2, 2025 |
| Scadden David | Director | SELL | $1K–$15K | 200 | $40.00 | Oct 2, 2025 |
| Jones Cecilia | CFO | SELL | $100K–$500K | 4K | $36.77 | Sep 30, 2025 |
| Jones Cecilia | CFO | EXERCISE | N/A | 7K | — | Sep 30, 2025 |
| Washburn Theodore James Jr. | Principal Accounti… | SELL | $100K–$500K | 9K | $36.87 | Sep 9, 2025 |
| Scadden David | Director | EXERCISE | $1K–$15K | 200 | $18.09 | Aug 29, 2025 |
| Scadden David | Director | SELL | $1K–$15K | 200 | $40.00 | Aug 29, 2025 |
| Scadden David | Director | EXERCISE | $15K–$50K | 1K | $18.09 | Jul 15, 2025 |
| Scadden David | Director | SELL | $50K–$100K | 1K | $40.00 | Jul 15, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $100K–$500K | 12K | $37.99 | Jul 11, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | $100K–$500K | 12K | $25.01 | Jul 11, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $100K–$500K | 4K | $34.17 | Jul 3, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | N/A | 8K | — | Jul 3, 2025 |
| Burns James William | Chief Legal Officer | SELL | $50K–$100K | 3K | $33.54 | Jun 26, 2025 |
| Burns James William | Chief Legal Officer | EXERCISE | N/A | 6K | — | Jun 26, 2025 |
| Gheuens Sarah | Chief Medical Offi… | EXERCISE | N/A | 6K | — | Jun 26, 2025 |
| Gheuens Sarah | Chief Medical Offi… | SELL | $50K–$100K | 3K | $33.54 | Jun 26, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 178 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| STATE STREET CORP | 3.1M | $1M+ | SH |
| Erste Asset Management GmbH | 2.8M | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.7M | $1M+ | SH |
| MPM BioImpact LLC | 1.3M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 1.3M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $1M+ | SH |
| BNP Paribas Asset Management Holding S.A. | 1.2M | $1M+ | SH |
| GW&K Investment Management, LLC | 1.2M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 950K | $1M+ | SH |
| Capital International Investors | 704K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 635K | $1M+ | SH |
| SCS Capital Management LLC | 599K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 563K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 483K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 466K | $1M+ | SH |
| BARCLAYS PLC | 320K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 243K | $1M+ | SH |
| Palo Alto Investors LP | 212K | $1M+ | SH |
| Pictet Asset Management Holding SA | 205K | $1M+ | SH |
| Point72 Asset Management, L.P. | 200K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 18, 2026
5.2%
3.0M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 9, 2026
0.7%
413K shares
SC 13G · Feb 9, 2026
5.3%
3.1M shares
SC 13G/A · Dec 5, 2025
0.0%
0 shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2025
4.9%
2.9M shares
Paradigm BioCapital Advisors LP
SC 13G · Aug 28, 2025
5.2%
3.0M shares
SC 13G/A · Jul 17, 2025
7.8%
4.5M shares
SC 13G · Jul 7, 2025
6.1%
3.5M shares
SC 13G/A · Jun 13, 2025
0.0%
0 shares
SC 13G/A · Feb 14, 2025
6.2%
3.5M shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 4, 2025
0.7%
422K shares
SC 13G/A · Nov 14, 2024
3.9%
2.2M shares
Farallon Capital Partners, L.P.
SC 13G/A · Nov 8, 2024
0.7%
422K shares
SC 13G/A · Feb 14, 2024
6.3%
3.5M shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2024
3.9%
2.2M shares
SC 13G/A · Feb 13, 2024
7.2%
4.0M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 12, 2024
10.0%
5.6M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 12, 2024
9.9%
5.5M shares
SC 13G/A · Jan 25, 2024
8.9%
5.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 22, 2024
4.7%
0 shares
Farallon Capital Partners, L.P.
SC 13G · Nov 9, 2023
0.6%
332K shares
Wellington Management Group LLP
SC 13G/A · Nov 9, 2023
4.0%
2.2M shares
Wellington Management Group LLP
SC 13G/A · Apr 10, 2023
10.3%
5.7M shares
SC 13G/A · Feb 14, 2023
7.3%
4.0M shares
Rock Springs Capital Management LP
SC 13G · Feb 14, 2023
5.5%
3.0M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
2.7%
1.5M shares
SC 13G · Feb 14, 2023
5.0%
2.8M shares
SC 13G/A · Jan 25, 2023
8.7%
4.8M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G/A · Oct 6, 2022
2.7%
1.5M shares
SC 13G/A · Sep 12, 2022
3.7%
2.0M shares
SC 13G/A · Mar 9, 2022
10.1%
5.5M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Feb 14, 2022
5.3%
2.9M shares
SC 13G/A · Feb 11, 2022
7.9%
4.3M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Jan 19, 2022
5.7%
3.1M shares